Chronic Kidney Disease News

Patients with HIV who undergo immediate antiretroviral therapy may not experience significant differences in chronic kidney disease outcomes compared with patients who defer treatment.

In this video, Shuchi Anand, MD, MS, discusses the importance of shared decision-making and patient-provider partnerships in personalized treatment plans for chronic kidney disease.

Matrix metalloproteinase 2 may be associated with the progression of chronic kidney disease, especially in patients with low inflammation or with proteinuria, data show.

Critically ill Chinese American patients in an ICU were less likely to receive kidney replacement therapy at the end of life compared with patients researchers described as white Americans, published data show.

Novo Nordisk has stopped phase 3 clinical trials for its drug ocedurenone after it failed to meet its primary endpoint for treating uncontrolled hypertension in patients with advanced chronic kidney disease, according to a company press release.

Eating a variety of natural fiber-rich foods and avoiding fiber with phosphate additives may help youth with chronic kidney disease to meet adequate dietary fiber intake.

The top three home dialysis barriers cited by patients, caregivers and providers do not fully overlap, which suggests the need for diverse strategies for each group, according to a study.

CKD results in gradual damage to a patient’s kidneys over time, prevents the kidneys from properly filtering blood and can ultimately lead to kidney failure, which can lead to death.

ORLANDO — Semaglutide use was associated with significant reductions in worsening of kidney disease, cardiovascular events and all-cause death vs. placebo for adults with type 2 diabetes regardless of concomitant use of SGLT2 inhibitors.

Some patients on in-center hemodialysis were able to successfully adapt to telehealth during the COVID-19 pandemic, but more research is needed on communication and privacy, data show.